BE FIRST TO KNOW WHAT IS HAPPENING IN COMPANY
Press Releases About
NOVA MENTIS
LATEST NEWS
Nova Mentis Psilocybin Approved for Shipment to Italy / Autism Treatment Study Underway

Vancouver, British Columbia – February 09, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that its proprietary drug psilocybin has been shipped to the …

READ MODE
Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study Develops Microbiome Diagnostic Index

Vancouver, British Columbia – January 26, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has commenced the diagnostic and treatment phase of …

READ MODE
Nova Mentis to be Listed in the First-Ever Psychedelic Index

Vancouver, British Columbia – January 25, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has been included in the world’s first North …

READ MODE
Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Vancouver, British Columbia – January 13, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has appointed Dr. Julia V. Perederiy, PhD to …

READ MODE
Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board

Vancouver, British Columbia – January 4, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has appointed Dr. Kyle H. Ambert, PhD to …

READ MODE
Nova Mentis Expands Psychedelic Drug Pipeline

  Vancouver, British Columbia – December 29, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has added two additional psychedelic compounds to …

READ MODE
Nova Mentis Uncovers Diagnostic Biomarkers in Preclinical Autism Study

Vancouver, British Columbia – December 8, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has uncovered molecular and bacteriologic diagnostic markers in …

READ MODE